RMD

#439
ResMed Inc. Common Stock
190.6 3 USD
-7.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
190.40
193.42
Year Range
2.07
277.67
Daily Change
-7.07%
Monthly Change
-10.28%
6 month change
-20.57%
Year Change
-26.40%
Previous Close
205.1 4
Open
193.3 5
Low
190.4 0
High
193.4 2
Volume
1 890
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 27.65 B
  • Employee 11 K
  • Founded N/A
  • CEO Michael J. Farrell
  • Website www.resmed.com
  • Headquarter Delaware, United States
  • FIGI BBG000L4M7F1
  • Industry Medical Instruments & Supplies
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
21.65
Price to sales ratio
5.94
Dividends per share
0.6
Dividend yield %
1.75

ResMed Inc. Common Stock

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

News